Skip to main content
Signal8

Czuczman Myron

SEC insider (Form 3/4/5 filer). CIK 0001817716. Chief Medical Officer at CITIUS ONCOLOGY, INC. (CTOR) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 19, 2025. Located in CRANFORD, NJ.

Companies Czuczman Myron has filed insider reports for

  • CITIUS ONCOLOGY, INC. (CTOR): Officer, Chief Medical Officer
  • Citius Pharmaceuticals, Inc. (CTXR): Officer, Chief Medical Officer
Czuczman Myron profile photo

Czuczman Myron

CIK: 0001817716

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CITIUS ONCOLOGY, INC. logo
CTOR

CITIUS ONCOLOGY, INC.

Officer
Citius Pharmaceuticals, Inc. logo
CTXR

Citius Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • CITIUS ONCOLOGY, INC. logo
    CTOR

    CITIUS ONCOLOGY, INC.

    Sep 19, 2025
    Award
    Direct
    825K shares-
  • CITIUS ONCOLOGY, INC. logo
    CTOR

    CITIUS ONCOLOGY, INC.

    Dec 12, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    400K shares-
  • Citius Pharmaceuticals, Inc. logo
    CTXR

    Citius Pharmaceuticals, Inc.

    Nov 7, 2024
    Award

    Stock Option (Right to Purchase Common Stock)

    Direct
    300K shares-

1-3 of 3